Download PDF
Semin Reprod Med 2009; 27(1): 080-089
DOI: 10.1055/s-0028-1108012
© Thieme Medical Publishers

Regulation of Angiogenesis in the Primate Endometrium: Vascular Endothelial Growth Factor

Krishna P. Chennazhi1 , Nihar R. Nayak1
  • 1Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, California
Further Information

Publication History

Publication Date:
05 February 2009 (online)

    Permissions and Reprints

ABSTRACT

Unlike other tissues, endometrial vessels are unique because their functions are primarily orchestrated under the influence of ovarian steroid hormones, estradiol and progesterone. Although there is controversy in the literature on the expression of steroid hormone receptors in endometrial endothelial and vascular smooth muscle cells, it is believed that the actions of estradiol and progesterone are primarily mediated by paracrine interactions between the vascular and other cells of the endometrium. However, the regulatory mechanisms and local factors involved in mediating these paracrine interactions are not fully understood. Numerous angiogenic factors have been identified and implicated in endometrial vascular development and differentiation, but their relative contribution in endometrial angiogenesis is unknown. This review primarily focuses on the current progress in understanding the roles of a prototypical angiogenic factor, the vascular endothelial growth factor (VEGF), in the primate endometrium. Regulation of VEGF and its receptors in the endometrium appears to be highly complex, regulated by both steroid hormones as well as local factors independent of steroid hormones. The zone-specific and the cell-type specific expression of VEGF and its receptors in the endometrium suggest that steroid hormones likely regulate their expression through local cell-specific regulatory factors, rather than through direct gene transcription. Because VEGF receptors are expressed in both endothelial and nonendothelial cells, VEGF may have a pleiotropic role in this tissue. Recent development of highly potent VEGF inhibitors provides an opportunity to study the roles of VEGF in the primate endometrium. It is imperative that future studies focus on understanding specific roles of VEGF using these inhibitors, which is critically needed for development of new therapeutic strategies for numerous endometrial vascular disorders.

KEYWORDS

Vascular endothelial growth factor (VEGF) - endometrium - angiogenesis - estrogen - progesterone

REFERENCES

  • 1 Hess A P, Nayak N R, Giudice L C. Oviduct and endometrium: cyclic changes in the primate oviduct and endometrium. In: Neill JD Knobil and Neill's Physiology of Reproduction. Vol. 1. New York, NY; Elsevier Science & Technology Books 2005: 337-381
    Google Scholar
  • 2 Brenner R M, Rudolph L, Matrisian L, Slayden O D. Non-human primate models; artificial menstrual cycles, endometrial matrix metalloproteinases and s.c. endometrial grafts.  Hum Reprod. 1996;  11(suppl 2) 150-164
    PubMedGoogle Scholar
  • 3 Markee J E. Menstruation in intraocular endometrial transplants in the rhesus monkey.  Contrib Embryol. 1940;  28 219-308
    PubMedGoogle Scholar
  • 4 Ramsey E M. Vascular anatomy. In: Wynn RM Biology of the Uterus. Volume 2. New York, NY; Plenum Press 1982: 59-76
    Google Scholar
  • 5 Bartelmez G W. The phases of the menstrual cycle and their interpretation in terms of the pregnancy cycle.  Am J Obstet Gynecol. 1957;  74(5) 931-955
    PubMedGoogle Scholar
  • 6 Rogers P A. Structure and function of endometrial blood vessels.  Hum Reprod Update. 1996;  2(1) 57-62
    CrossrefPubMedGoogle Scholar
  • 7 Bartelmez G W. The form and functions of the uterine blood vessels in the rhesus monkey.  Contrib Embryol. 1957;  249 155-181
    PubMedGoogle Scholar
  • 8 Nayak N R, Brenner R M. Vascular proliferation and vascular endothelial growth factor expression in the rhesus macaque endometrium.  J Clin Endocrinol Metab. 2002;  87(4) 1845-1855
    CrossrefPubMedGoogle Scholar
  • 9 Ferenczy A, Bertrand G, Gelfand M M. Proliferation kinetics of human endometrium during the normal menstrual cycle.  Am J Obstet Gynecol. 1979;  133(8) 859-867
    PubMedGoogle Scholar
  • 10 Rogers P A, Gargett C E. Endometrial angiogenesis.  Angiogenesis. 1998;  2(4) 287-294
    CrossrefPubMedGoogle Scholar
  • 11 Goodger A M, Rogers P A. Endometrial endothelial cell proliferation during the menstrual cycle.  Hum Reprod. 1994;  9(3) 399-405
    PubMedGoogle Scholar
  • 12 Rogers P A, Abberton K M. Endometrial arteriogenesis: vascular smooth muscle cell proliferation and differentiation during the menstrual cycle and changes associated with endometrial bleeding disorders.  Microsc Res Tech. 2003;  60(4) 412-419
    CrossrefPubMedGoogle Scholar
  • 13 Nayak N R, Kuo C J, Desai T A et al.. Expression, localization and hormonal control of angiopoietin-1 in the rhesus macaque endometrium: potential role in spiral artery growth.  Mol Hum Reprod. 2005;  11(11) 791-799
    PubMedGoogle Scholar
  • 14 Lubahn D B, Moyer J S, Golding T S, Couse J F, Korach K S, Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene.  Proc Natl Acad Sci U S A. 1993;  90(23) 11162-11166
    CrossrefPubMedGoogle Scholar
  • 15 Brenner R M, Slayden O D. Steroid receptors in blood vessels of the rhesus macaque endometrium: a review.  Arch Histol Cytol. 2004;  67(5) 411-416
    CrossrefPubMedGoogle Scholar
  • 16 Iruela-Arispe M L, Rodriguez-Manzaneque J C, Abu-Jawdeh G. Endometrial endothelial cells express estrogen and progesterone receptors and exhibit a tissue specific response to angiogenic growth factors.  Microcirculation. 1999;  6(2) 127-140
    CrossrefPubMedGoogle Scholar
  • 17 Press M F, Udove J A, Greene G L. Progesterone receptor distribution in the human endometrium. Analysis using monoclonal antibodies to the human progesterone receptor.  Am J Pathol. 1988;  131(1) 112-124
    PubMedGoogle Scholar
  • 18 Critchley H O, Brenner R M, Henderson T A et al.. Estrogen receptor beta, but not estrogen receptor alpha, is present in the vascular endothelium of the human and nonhuman primate endometrium.  J Clin Endocrinol Metab. 2001;  86(3) 1370-1378
    CrossrefPubMedGoogle Scholar
  • 19 Lecce G, Meduri G, Ancelin M, Bergeron C, Perrot-Applanat M. Presence of estrogen receptor beta in the human endometrium through the cycle: expression in glandular, stromal, and vascular cells.  J Clin Endocrinol Metab. 2001;  86(3) 1379-1386
    CrossrefPubMedGoogle Scholar
  • 20 Krikun G, Schatz F, Taylor R et al.. Endometrial endothelial cell steroid receptor expression and steroid effects on gene expression.  J Clin Endocrinol Metab. 2005;  90(3) 1812-1818
    CrossrefPubMedGoogle Scholar
  • 21 Silvestri A, Fraser H M. Oestrogen and progesterone receptors in the marmoset endometrium: changes during the ovulatory cycle, early pregnancy and after inhibition of vascular endothelial growth factor, GnRH or ovariectomy.  Reproduction. 2007;  134(2) 341-353
    CrossrefPubMedGoogle Scholar
  • 22 Wehling M. Nongenomic aldosterone effects: the cell membrane as a specific target of mineralocorticoid action.  Steroids. 1995;  60(1) 153-156
    CrossrefPubMedGoogle Scholar
  • 23 Simoncini T, Genazzani A R, Liao J K. Nongenomic mechanisms of endothelial nitric oxide synthase activation by the selective estrogen receptor modulator raloxifene.  Circulation. 2002;  105(11) 1368-1373
    CrossrefPubMedGoogle Scholar
  • 24 Dvorak H F. Angiogenesis: update 2005.  J Thromb Haemost. 2005;  3(8) 1835-1842
    CrossrefPubMedGoogle Scholar
  • 25 Carmeliet P. Angiogenesis in life, disease and medicine.  Nature. 2005;  438(7070) 932-936
    CrossrefPubMedGoogle Scholar
  • 26 Ferrara N. Vascular endothelial growth factor and the regulation of angiogenesis.  Recent Prog Horm Res. 2000;  55 15-35 discussion 35-36
    PubMedGoogle Scholar
  • 27 Girling J E, Rogers P A. Recent advances in endometrial angiogenesis research.  Angiogenesis. 2005;  8(2) 89-99
    CrossrefPubMedGoogle Scholar
  • 28 Risau W. Mechanisms of angiogenesis.  Nature. 1997;  386(6626) 671-674
    CrossrefPubMedGoogle Scholar
  • 29 Asahara T, Masuda H, Takahashi T et al.. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization.  Circ Res. 1999;  85(3) 221-228
    CrossrefPubMedGoogle Scholar
  • 30 Burri P H, Djonov V. Intussusceptive angiogenesis—the alternative to capillary sprouting.  Mol Aspects Med. 2002;  23(6S) S1-S27
    PubMedGoogle Scholar
  • 31 Hewett P, Nijjar S, Shams M, Morgan S, Gupta J, Ahmed A. Down-regulation of angiopoietin-1 expression in menorrhagia.  Am J Pathol. 2002;  160(3) 773-780
    CrossrefPubMedGoogle Scholar
  • 32 Hirchenhain J, Huse I, Hess A, Bielfeld P, De Bruyne F, Krussel J S. Differential expression of angiopoietins 1 and 2 and their receptor Tie-2 in human endometrium.  Mol Hum Reprod. 2003;  9(11) 663-669
    CrossrefPubMedGoogle Scholar
  • 33 Krikun G, Critchley H, Schatz F et al.. Abnormal uterine bleeding during progestin-only contraception may result from free radical-induced alterations in angiopoietin expression.  Am J Pathol. 2002;  161(3) 979-986
    PubMedGoogle Scholar
  • 34 Nelson K G, Takahashi T, Bossert N L, Walmer D K, McLachlan J A. Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation.  Proc Natl Acad Sci U S A. 1991;  88(1) 21-25
    PubMedGoogle Scholar
  • 35 Ferriani R A, Charnock-Jones D S, Prentice A, Thomas E J, Smith S K. Immunohistochemical localization of acidic and basic fibroblast growth factors in normal human endometrium and endometriosis and the detection of their mRNA by polymerase chain reaction.  Hum Reprod. 1993;  8(1) 11-16
    PubMedGoogle Scholar
  • 36 Samathanam C A, Adesanya O O, Zhou J, Wang J, Bondy C A. Fibroblast growth factors 1 and 2 in the primate uterus.  Biol Reprod. 1998;  59(3) 491-496
    CrossrefPubMedGoogle Scholar
  • 37 Gold L I, Saxena B, Mittal K R et al.. Increased expression of transforming growth factor beta isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: evidence for paracrine and autocrine action.  Cancer Res. 1994;  54(9) 2347-2358
    PubMedGoogle Scholar
  • 38 Horowitz G M, Scott Jr R T, Drews M R, Navot D, Hofmann G E. Immunohistochemical localization of transforming growth factor-alpha in human endometrium, decidua, and trophoblast.  J Clin Endocrinol Metab. 1993;  76(3) 786-792
    CrossrefPubMedGoogle Scholar
  • 39 Chegini N, Rossi M J, Masterson B J. Platelet-derived growth factor (PDGF), epidermal growth factor (EGF), and EGF and PDGF beta-receptors in human endometrial tissue: localization and in vitro action.  Endocrinology. 1992;  130(4) 2373-2385
    CrossrefPubMedGoogle Scholar
  • 40 Yasuda Y, Masuda S, Chikuma M, Inoue K, Nagao M, Sasaki R. Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis.  J Biol Chem. 1998;  273(39) 25381-25387
    CrossrefPubMedGoogle Scholar
  • 41 Zhao D, Li X P, Gao M, Zhao C, Wang J L, Wei L H. Stromal cell-derived factor 1alpha stimulates human endometrial carcinoma cell growth through the activation of both extracellular signal-regulated kinase 1/2 and Akt.  Gynecol Oncol. 2006;  103(3) 932-937
    CrossrefPubMedGoogle Scholar
  • 42 Ahmed A, Dearn S. The role of platelet-activating factor and its receptor in endometrial receptivity.  Adv Exp Med Biol. 1996;  416 277-290
    PubMedGoogle Scholar
  • 43 Tsutsui J, Uehara K, Kadomatsu K, Matsubara S, Muramatsu T. A new family of heparin-binding factors: strong conservation of midkine (MK) sequences between the human and the mouse.  Biochem Biophys Res Commun. 1991;  176(2) 792-797
    CrossrefPubMedGoogle Scholar
  • 44 Zhao Y, Hague S, Manek S, Zhang L, Bicknell R, Rees M C. PCR display identifies tamoxifen induction of the novel angiogenic factor adrenomedullin by a non estrogenic mechanism in the human endometrium.  Oncogene. 1998;  16(3) 409-415
    CrossrefPubMedGoogle Scholar
  • 45 Frater-Schroder M, Risau W, Hallmann R, Gautschi P, Bohlen P. Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo.  Proc Natl Acad Sci U S A. 1987;  84(15) 5277-5281
    PubMedGoogle Scholar
  • 46 Marsh M M, Hampton A L, Riley S C, Findlay J K, Salamonsen L A. Production and characterization of endothelin released by human endometrial epithelial cells in culture.  J Clin Endocrinol Metab. 1994;  79(6) 1625-1631
    CrossrefPubMedGoogle Scholar
  • 47 Philippeaux M M, Piguet P F. Expression of tumor necrosis factor-alpha and its mRNA in the endometrial mucosa during the menstrual cycle.  Am J Pathol. 1993;  143(2) 480-486
    PubMedGoogle Scholar
  • 48 Tabibzadeh S, Kong Q F, Kapur S, Satyaswaroop P G, Aktories K. Tumour necrosis factor-alpha-mediated dyscohesion of epithelial cells is associated with disordered expression of cadherin/beta-catenin and disassembly of actin filaments.  Hum Reprod. 1995;  10(4) 994-1004
    PubMedGoogle Scholar
  • 49 Charnock-Jones D S, Sharkey A M, Rajput-Williams J et al.. Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines.  Biol Reprod. 1993;  48(5) 1120-1128
    CrossrefPubMedGoogle Scholar
  • 50 Shifren J L, Tseng J F, Zaloudek C J et al.. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis.  J Clin Endocrinol Metab. 1996;  81(8) 3112-3118
    CrossrefPubMedGoogle Scholar
  • 51 Torry D S, Holt V J, Keenan J A, Harris G, Caudle M R, Torry R J. Vascular endothelial growth factor expression in cycling human endometrium.  Fertil Steril. 1996;  66(1) 72-80
    PubMedGoogle Scholar
  • 52 Ancelin M, Buteau-Lozano H, Meduri G et al.. A dynamic shift of VEGF isoforms with a transient and selective progesterone-induced expression of VEGF189 regulates angiogenesis and vascular permeability in human uterus.  Proc Natl Acad Sci U S A. 2002;  99(9) 6023-6028
    CrossrefPubMedGoogle Scholar
  • 53 Gluzman-Poltorak Z, Cohen T, Herzog Y, Neufeld G. Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165.  J Biol Chem. 2000;  275(24) 18040-18045
    CrossrefPubMedGoogle Scholar
  • 54 Soker S, Miao H Q, Nomi M, Takashima S, Klagsbrun M. VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding.  J Cell Biochem. 2002;  85(2) 357-368
    CrossrefPubMedGoogle Scholar
  • 55 Soker S, Takashima S, Miao H Q, Neufeld G, Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.  Cell. 1998;  92(6) 735-745
    CrossrefPubMedGoogle Scholar
  • 56 Germeyer A, Hamilton A E, Laughlin L S et al.. Cellular expression and hormonal regulation of neuropilin-1 and -2 messenger ribonucleic acid in the human and rhesus macaque endometrium.  J Clin Endocrinol Metab. 2005;  90(3) 1783-1790
    PubMedGoogle Scholar
  • 57 Nayak N R, Critchley H O, Slayden O D et al.. Progesterone withdrawal up-regulates vascular endothelial growth factor receptor type 2 in the superficial zone stroma of the human and macaque endometrium: potential relevance to menstruation.  J Clin Endocrinol Metab. 2000;  85(9) 3442-3452
    CrossrefPubMedGoogle Scholar
  • 58 Greb R R, Heikinheimo O, Williams R F, Hodgen G D, Goodman A L. Vascular endothelial growth factor in primate endometrium is regulated by oestrogen-receptor and progesterone-receptor ligands in vivo.  Hum Reprod. 1997;  12(6) 1280-1292
    CrossrefPubMedGoogle Scholar
  • 59 Bausero P, Cavaille F, Meduri G, Freitas S, Perrot-Applanat M. Paracrine action of vascular endothelial growth factor in the human endometrium: production and target sites, and hormonal regulation.  Angiogenesis. 1998;  2(2) 167-182
    CrossrefPubMedGoogle Scholar
  • 60 Li X F, Gregory J, Ahmed A. Immunolocalisation of vascular endothelial growth factor in human endometrium.  Growth Factors. 1994;  11(4) 277-282
    PubMedGoogle Scholar
  • 61 Punyadeera C, Thijssen V L, Tchaikovski S et al.. Expression and regulation of vascular endothelial growth factor ligands and receptors during menstruation and post-menstrual repair of human endometrium.  Mol Hum Reprod. 2006;  12(6) 367-375
    CrossrefPubMedGoogle Scholar
  • 62 Taylor R N, Lebovic D I, Hornung D, Mueller M D. Endocrine and paracrine regulation of endometrial angiogenesis.  Ann N Y Acad Sci. 2001;  943 109-121
    PubMedGoogle Scholar
  • 63 Huang J C, Liu D Y, Dawood M Y. The expression of vascular endothelial growth factor isoforms in cultured human endometrial stromal cells and its regulation by 17beta-oestradiol.  Mol Hum Reprod. 1998;  4(6) 603-607
    CrossrefPubMedGoogle Scholar
  • 64 Mueller M D, Vigne J L, Minchenko A, Lebovic D I, Leitman D C, Taylor R N. Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta.  Proc Natl Acad Sci U S A. 2000;  97(20) 10972-10977
    CrossrefPubMedGoogle Scholar
  • 65 Niklaus A L, Babischkin J S, Aberdeen G W, Pepe G J, Albrecht E D. Expression of vascular endothelial growth/permeability factor by endometrial glandular epithelial and stromal cells in baboons during the menstrual cycle and after ovariectomy.  Endocrinology. 2002;  143(10) 4007-4017
    CrossrefPubMedGoogle Scholar
  • 66 Albrecht E D, Aberdeen G W, Niklaus A L, Babischkin J S, Suresch D L, Pepe G J. Acute temporal regulation of vascular endothelial growth/permeability factor expression and endothelial morphology in the baboon endometrium by ovarian steroids.  J Clin Endocrinol Metab. 2003;  88(6) 2844-2852
    CrossrefPubMedGoogle Scholar
  • 67 Charnock-Jones D S, Macpherson A M, Archer D F et al.. The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium.  Hum Reprod. 2000;  15(suppl 3) 85-95
    PubMedGoogle Scholar
  • 68 Meduri G, Bausero P, Perrot-Applanat M. Expression of vascular endothelial growth factor receptors in the human endometrium: modulation during the menstrual cycle.  Biol Reprod. 2000;  62(2) 439-447
    PubMedGoogle Scholar
  • 69 Herve M A, Meduri G, Petit F G et al.. Regulation of the vascular endothelial growth factor (VEGF) receptor Flk-1/KDR by estradiol through VEGF in uterus.  J Endocrinol. 2006;  188(1) 91-99
    CrossrefPubMedGoogle Scholar
  • 70 Sharkey A M, Day K, McPherson A et al.. Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia.  J Clin Endocrinol Metab. 2000;  85(1) 402-409
    CrossrefPubMedGoogle Scholar
  • 71 Semenza G L. HIF-1: using two hands to flip the angiogenic switch.  Cancer Metastasis Rev. 2000;  19(1–2) 59-65
    CrossrefPubMedGoogle Scholar
  • 72 Critchley H O, Osei J, Henderson T A et al.. Hypoxia-inducible factor-1alpha expression in human endometrium and its regulation by prostaglandin E-series prostanoid receptor 2 (EP2).  Endocrinology. 2006;  147(2) 744-753
    PubMedGoogle Scholar
  • 73 Popovici R M, Irwin J C, Giaccia A J, Giudice L C. Hypoxia and cAMP stimulate vascular endothelial growth factor (VEGF) in human endometrial stromal cells: potential relevance to menstruation and endometrial regeneration.  J Clin Endocrinol Metab. 1999;  84(6) 2245-2248
    CrossrefPubMedGoogle Scholar
  • 74 Tuder R M, Flook B E, Voelkel N F. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide.  J Clin Invest. 1995;  95(4) 1798-1807
    CrossrefPubMedGoogle Scholar
  • 75 Li J, Brown L F, Hibberd M G, Grossman J D, Morgan J P, Simons M. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis.  Am J Physiol. 1996;  270(5 Pt 2) H1803-H1811
    PubMedGoogle Scholar
  • 76 Brogi E, Schatteman G, Wu T et al.. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression.  J Clin Invest. 1996;  97(2) 469-476
    PubMedGoogle Scholar
  • 77 Gerber H P, Condorelli F, Park J, Ferrara N. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia.  J Biol Chem. 1997;  272(38) 23659-23667
    CrossrefPubMedGoogle Scholar
  • 78 Flamme I, Breier G, Risau W. Vascular endothelial growth factor (VEGF) and VEGF receptor 2 (flk-1) are expressed during vasculogenesis and vascular differentiation in the quail embryo.  Dev Biol. 1995;  169(2) 699-712
    CrossrefPubMedGoogle Scholar
  • 79 Wang H, Keiser J A. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1.  Circ Res. 1998;  83(8) 832-840
    PubMedGoogle Scholar
  • 80 Singer A J, Clark R A. Cutaneous wound healing.  N Engl J Med. 1999;  341(10) 738-746
    CrossrefPubMedGoogle Scholar
  • 81 Brown L F, Yeo K T, Berse B et al.. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing.  J Exp Med. 1992;  176(5) 1375-1379
    CrossrefPubMedGoogle Scholar
  • 82 Peters K G, De Vries C, Williams L T. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth.  Proc Natl Acad Sci U S A. 1993;  90(19) 8915-8919
    CrossrefPubMedGoogle Scholar
  • 83 Frank S, Hubner G, Breier G, Longaker M T, Greenhalgh D G, Werner S. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing.  J Biol Chem. 1995;  270(21) 12607-12613
    CrossrefPubMedGoogle Scholar
  • 84 Lauer G, Sollberg S, Cole M et al.. Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds.  J Invest Dermatol. 2000;  115(1) 12-18
    CrossrefPubMedGoogle Scholar
  • 85 Howdieshell T R, Callaway D, Webb W L et al.. Antibody neutralization of vascular endothelial growth factor inhibits wound granulation tissue formation.  J Surg Res. 2001;  96(2) 173-182
    CrossrefPubMedGoogle Scholar
  • 86 Jacobi J, Tam B Y, Sundram U et al.. Discordant effects of a soluble VEGF receptor on wound healing and angiogenesis.  Gene Ther. 2004;  11(3) 302-309
    CrossrefPubMedGoogle Scholar
  • 87 Brown L F, Detmar M, Claffey K et al.. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine.  EXS. 1997;  79 233-269
    PubMedGoogle Scholar
  • 88 Gargett C E, Rogers P A. Human endometrial angiogenesis.  Reproduction. 2001;  121(2) 181-186
    CrossrefPubMedGoogle Scholar
  • 89 Gargett C E, Lederman F L, Lau T M, Taylor N H, Rogers P A. Lack of correlation between vascular endothelial growth factor production and endothelial cell proliferation in the human endometrium.  Hum Reprod. 1999;  14(8) 2080-2088
    CrossrefPubMedGoogle Scholar
  • 90 Goodger A M, Rogers P A, Affandi B. Endometrial endothelial cell proliferation in long-term users of subdermal levonorgestrel.  Hum Reprod. 1994;  9(9) 1647-1651
    PubMedGoogle Scholar
  • 91 Nayak N R, Brenner R M, Wiegand S J, Giudice L C. Blockade of vascular development in the rhesus macaque endometrium by treatment with VEGF-trap: role of VEGF in postmenstrual endometrial angiogenesis.  J Soc Gynecol Investig. 2004;  11(suppl) 186A
    PubMedGoogle Scholar
  • 92 Ferrara N, Kerbel R S. Angiogenesis as a therapeutic target.  Nature. 2005;  438(7070) 967-974
    CrossrefPubMedGoogle Scholar

Nihar R Nayak

Department of Obstetrics and Gynecology, Stanford University School of Medicine

300 Pasteur Drive, HH-333, Stanford, CA 94305

Email: nayakn@stanford.edu

      >